investors

we are relentless in our pursuit of excellence

creating true shareholder value

The Aalberts way of value creation is to achieve unique worldwide leading market positions with niche technologies in selective end markets. Relentlessly running the Aalberts playbook results in long-term shareholder value. Our track record of more than 45 years of sustainable profitable growth proves the sustainability of our business model.

01
reasons to invest
Aalberts Playbook
dummy
Aalberts Playbook

the Aalberts playbook relentless pursuit of excellence

Our playbook? Achieving compelling competitive advantage, driving margin expansion through operational leverage and excellence, converting strong operational execution into free cash flow and continuously optimising our portfolio through disciplined capital allocation, achieving compounding returns.

actual

10 year

Euronext Amsterdam AALB
32.18
change
-3.13%
close
33.22

financial calendar

all investor events

financial calendar

5 March 2025
London
Berenberg London conference
13 March 2025
registration date General Meeting
18 March 2025
London
Bank of America London Conference
31 March 2025
Madrid
Degroof Petercam Madrid Conference
10 April 2025
General Meeting
14 April 2025
quotation ex-dividend
15 April 2025
record date for dividend
2 May 2025
publication results Q1 2025
8 May 2025
paying out dividend
21 May 2025
New York
Berenberg New York Conference
10 June 2025
London
KBC London Conference
17 June 2025
London
ABN AMRO ODDO London Conference
24 July 2025
publication results first half year 2025
4 September 2025
New York
Jefferies New York Conference
23 October 2025
publication results Q3 2025
25 November 2025
Brussels
ING Brussels Conference
3 December 2025
London
Berenberg London Conference
9 December 2025
New York
ING New York Conference
26 February 2026
publication results full year 2025
9 April 2026
General Meeting
05 March 2025
London
Berenberg London conference
13 March 2025
registration date General Meeting
18 March 2025
London
Bank of America London Conference
31 March 2025
Madrid
Degroof Petercam Madrid Conference
10 April 2025
General Meeting
14 April 2025
quotation ex-dividend
15 April 2025
record date for dividend
02 May 2025
publication results Q1 2025
08 May 2025
paying out dividend
21 May 2025
New York
Berenberg New York Conference
10 June 2025
London
KBC London Conference
17 June 2025
London
ABN AMRO ODDO London Conference
24 July 2025
publication results first half year 2025
04 September 2025
New York
Jefferies New York Conference
23 October 2025
publication results Q3 2025
25 November 2025
Brussels
ING Brussels Conference
03 December 2025
London
Berenberg London Conference
09 December 2025
New York
ING New York Conference
26 February 2026
publication results full year 2025
09 April 2026
General Meeting

our track record shareholder value creation

Share price
Earnings per share
Dividends per share
Long term shareholders

strategy & objectives

investor strategy

accelerating leadership positions in three attractive end markets with a balanced portfolio

investor strategy

realising sustainable profitable growth with enhanced offerings, differentiated technology and innovation

investor strategy

driving customer-centric supply chain converting into margin and free cash flow improvement

investor strategy

allocating capital in a disciplined way supporting our profitable growth and high shareholder returns

investor strategy

realising sustainable commitments towards net zero carbon, using sustainability as a growth driver

investor strategy

enhancing the Aalberts way with our values, lean and effective structure and functional excellence

Aalberts objectives 2030
> 4.5
revenue (in EUR billion)
> 18 %
EBITA margin (% of revenue)
> 65 %
free cash flow conversion ratio
> 18 %
ROICE (10-year period)
< 2.5
leverage ratio

webcasts

2024
2023
2022
2021
2020
2019
archive

publications

annual report 2024
annual report 2024 (ESEF)
capital markets day December 2024
press release FY2024 results
trading update 7 November 2024
press release 1H2024 results
trading update 22 May 2024
presentation FY2024 results
presentation 1H2024 results
annual report 2023
annual report 2023 (ESEF)
press release FY2023 results
trading update 9 November 2023
press release 1H2023 results
trading update 24 May 2023
presentation FY2023 results
presentation 1H2023 results
investor day September 2022
annual report 2022
annual report 2022 (ESEF)
press release FY2022 results
trading update 9 November 2022
press release 1H2022 results
trading update 19 May 2022
presentation FY2022 results
presentation 1H2022 results
capital markets day December 2021
annual report 2021
annual report 2021 (ESEF)
press release FY2021 results
trading update 10 November 2021
press release 1H2021 results
trading update 11 May 2021
presentation FY2021 results
presentation 1H2021 results
annual report 2020
press release FY2020 results
trading update 26 October 2020
press release 1H2020 results
trading update 23 June 2020
COVID-19 update
presentation FY2020 results
presentation 1H2020 results
capital markets day December 2019
annual report 2019
press release FY2019 results
press release 1H2019 results
presentation FY2019 results
presentation 1H2019 results
annual report 2018
press releases 2018
annual report 2017
capital markets day December 2017
press releases 2017
annual report 2016
press releases 2016
annual report 2015
press releases 2015
annual report 2014
press releases 2014
annual report 2013
press releases 2013

analyst coverage

company recommendation target price
ABN AMRO Oddo BHF
Martijn den Drijver
outperform
8 November 2024
EUR 45.50
AlphaValue
Loco Douza
buy
29 January 2025
EUR 45.50
Bank of America
Alexander Virgo
buy
29 November 2024
EUR 41.00
Berenberg
Christoph Greulich
buy
13 December 2024
EUR 51.00
BNP Paribas
George Speak
outperform
12 March 2024
EUR 60.00
Degroof Petercam
Luuk van Beek
hold
27 February 2025
EUR 40.00
ING
Tijs Hollestelle
buy
24 October 2024
EUR 45.00
Jefferies
David Kerstens
buy
27 February 2025
EUR 45.00
KBC Securities
Kristof Samoy
accumulate
9 July 2024
EUR 45.00
Kepler Cheuvreux
Ruben Devos
hold
31 July 2024
EUR 37.00
Van Lanschot Kempen
Chase Coughlan
neutral
30 January 2025
EUR 37.00

 

disclaimer
Aalberts is followed by the analysts at these brokerage firms. The list may not be complete and is subject to change. Please note that any opinions, estimates or forecasts regarding Aalberts' performance made by the analysts at these brokerage firms are theirs alone and do not represent opinions, forecasts or predictions of Aalberts N.V. or its management. Aalberts N.V. does not by its reference above or distribution imply, and expressly disclaims, any endorsement of or concurrence with any information, estimates, forecasts, opinions, conclusions or recommendations provided by these analysts.

dividend

At the General Meeting of Aalberts N.V.,to be held on 10 April 2025, the dividend for the financial year 2024 is fixed at EUR 1.13 per share with a nominal value of EUR 0.25 each.

Holders of ordinary shares will receive the dividend through their bank or broker in whose custody the shares are held at the close of business (record date). The dividend will be made payable to them through ABN AMRO Bank N.V. In consultation with Aalberts, ABN AMRO Bank N.V. is offering a dividend reinvestment plan (DRIP) to holders of ordinary shares with a nominal value of EUR 0.25 each, who are holding their shares through Euroclear Nederland, whereby those shareholders have the opportunity to reinvest their net dividend in ordinary shares Aalberts N.V.

For further information about this subject you can contact your bank or broker or ABN AMRO Corporate Broking at +31 (0)20 628 6070

dividend policy
In the General Meeting of 2014, shareholders agreed to a dividend payment of 30% of net profit before amortisation, only to be paid in cash.

dividend history
in EUR per ordinary share
dividend history

shareholders >3% interest

The following shareholders with a substantial participating interest of more than 3% are registered with the AFM register substantial holdings, in accordance with the notification duty pursuant to the Dutch Financial Supervision Act:


shareholder interest disclosure date
Aalberts Beheer B.V., J. Aalberts,
J.A.M. Aalberts-Veen*
11.90% 13 May 2022
FMR LLC 9.99% 29 Feb 2024
BNP Paribas Asset Management Holding 5.02% 4 Feb 2025
Impax Asset Management 5.02% 25 Aug 2022
BlackRock Inc.  3.14% 20 Sep 2024

* disclosure based on interest as per registration date AGM 2022

shareholders

As from 14 July 2014 the number of outstanding shares Aalberts N.V. is 110,580,502. Last update 7 February 2025.

directors and members of the supervisory board

The following shares are held in accordance with the AFM register notifications directors and members of the supervisory board:


name
ordinary shares
conditional share awards
Stéphane Simonetta
CEO
15,000
39,000
Arno Monincx
CFO
15,000
20,000

corporate governance

Good corporate governance, including focus on sustainable long-term value creation and culture, is a key component of 'the Aalberts way' of doing business and is embedded in our core values. Aalberts endorses the principles of the Dutch Corporate Governance Code (the “Code”). The Code is available at www.mccg.nl. Our corporate governance structure has been updated in accordance with the Code in the past years.

Aalberts virtually applies all best practice provisions of the Code. To a limited extent, these have been adjusted to specific circumstances of Aalberts. As a result, the Management Board believes it meets the principles of ‘comply or explain’. The deviation from the Code relates to the following subject.

best practice provision 4.3.3 – binding nomination
The Articles of Association provide that the General Meeting can cancel the binding character of a nomination for appointment of a Managing Board member or of a Supervisory Board member, with a resolution passed with the maximum majority permitted by law. Currently, this majority is two-thirds of the votes cast representing more than half of the issued capital. The deviation relates to the well-balanced allocation of the control and influence of the company’s individual bodies as referred to in the paragraph ‘decision-making and priority shares’.

committees

There are two committees of the Supervisory Board: the Audit Committee and the Remuneration, Selection and Appointment Committee.
 
Audit Committee
The Audit Committee aids and advises the Supervisory Board in its responsibility to supervise the integrity and quality of the Aalberts’ financial reporting and the effectiveness of Aalberts’ internal risk management and control systems. The Audit Committee consists of Piet Veenema (chairman), Lieve Declercq and Thessa Menssen.

Nomination, Selection and Remuneration Committee
Nomination, Selection and Remuneration Committee (“NSR”) aids and advises the Supervisory Board on matters relating to the selection and appointment of the members of the Management Board and Supervisory Board. The NSR further monitors and evaluates the remuneration policy for the Management Board. The NSR consists of Jan van der Zouw (chairman), Peter van Bommel and Frank Melzer.

rotation schedule supervisory board

In line with the Code, Supervisory Board members can be appointed for a maximum of two 4-year terms and subsequently two 2-year terms.

name year of retirement
Peter van Bommel (Chairman) 2025
Lieve Declercq 2025
Frank Melzer 2027
Thessa Menssen 2027
Piet Veenema 2026
Jan van der Zouw 2025

general meeting

general meeting

any questions? Rutger Relker
director investor relations

investor updates

interested to stay informed?